14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.64 $2.30 Tuesday, 23rd Apr 2024 CTMX stock ended at $1.68. This is 0.599% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 5.49% from a day low at $1.64 to a day high of $1.73.
90 days $1.38 $2.86
52 weeks $1.04 $2.86

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Aug 18, 2020 $7.13 $7.38 $7.04 $7.18 335 072
Aug 17, 2020 $6.86 $7.26 $6.86 $7.16 628 331
Aug 14, 2020 $7.02 $7.14 $6.78 $6.87 319 001
Aug 13, 2020 $7.09 $7.21 $6.94 $7.00 335 427
Aug 12, 2020 $7.10 $7.34 $6.96 $7.07 461 827
Aug 11, 2020 $7.72 $7.72 $6.98 $6.99 622 395
Aug 10, 2020 $7.67 $7.90 $7.53 $7.62 284 664
Aug 07, 2020 $7.36 $8.10 $7.27 $7.62 420 586
Aug 06, 2020 $7.39 $7.61 $7.32 $7.55 310 485
Aug 05, 2020 $7.30 $7.54 $7.30 $7.45 288 690
Aug 04, 2020 $7.34 $7.47 $7.25 $7.28 261 267
Aug 03, 2020 $7.09 $7.39 $6.94 $7.37 553 840
Jul 31, 2020 $7.42 $7.44 $6.95 $7.01 576 904
Jul 30, 2020 $7.18 $7.55 $7.15 $7.44 427 267
Jul 29, 2020 $7.49 $7.63 $7.19 $7.27 473 589
Jul 28, 2020 $7.93 $7.93 $7.38 $7.40 492 654
Jul 27, 2020 $7.80 $8.09 $7.80 $7.92 748 715
Jul 24, 2020 $7.70 $7.93 $7.57 $7.76 558 366
Jul 23, 2020 $8.05 $8.20 $7.83 $7.92 281 243
Jul 22, 2020 $8.26 $8.36 $7.98 $8.06 318 000
Jul 21, 2020 $8.65 $8.65 $8.25 $8.29 333 800
Jul 20, 2020 $8.63 $8.75 $8.49 $8.57 208 300
Jul 17, 2020 $8.49 $8.68 $8.43 $8.62 241 100
Jul 16, 2020 $8.76 $8.76 $8.46 $8.51 365 800
Jul 15, 2020 $8.75 $9.15 $8.65 $8.83 562 800
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT